Literature DB >> 4359162

Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy.

J D Parkes, G W Fenton.   

Abstract

The narcoleptic syndrome is a life-long and sometimes familial disorder in which there is a disturbance of the rapid eye movement phase of sleep. Patients with periodic sleep in the daytime but no other symptoms seldom develop the narcoleptic syndrome and have a separate unrelated disorder. Twelve patients with the narcoleptic syndrome were treated separately with l(-) amphetamine and d(+) amphetamine. Both drugs abolished narcolepsy, d(+) amphetamine being slightly more potent than l(-) amphetamine. In equipotent doses, unwanted effects of nervousness and insomnia were equal in frequency. No tolerance to either preparation developed during a six month period. Cataplexy was not affected by amphetamine treatment, but was abolished in two patients when clomipramine was given together with either amphetamine.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4359162      PMCID: PMC1083612          DOI: 10.1136/jnnp.36.6.1076

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Cataplexy and other related forms of seizure.

Authors:  C SYMONDS
Journal:  Can Med Assoc J       Date:  1954-06       Impact factor: 8.262

2.  Effects of the amphetamine group on intraneuronal brain amines in vivo and in vitro.

Authors:  A Carlsson; M Lindqvist; A Dahlström; K Fuxe; D Masuoka
Journal:  J Pharm Pharmacol       Date:  1965-08       Impact factor: 3.765

3.  Treatment of intractable narcolepsy with a monoamine oxidase inhibitor.

Authors:  R J Wyatt; D H Fram; R Buchbinder; F Snyder
Journal:  N Engl J Med       Date:  1971-10-28       Impact factor: 91.245

4.  The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs.

Authors:  S H Snyder; K M Taylor; J T Coyle; J L Meyerhoff
Journal:  Am J Psychiatry       Date:  1970-08       Impact factor: 18.112

5.  Diethyldithiocarbamate and amphetamine stereotype behavior.

Authors:  A Randrup; J Scheel-Krüger
Journal:  J Pharm Pharmacol       Date:  1966-11       Impact factor: 3.765

6.  [Gélineau's syndrome and cerebellar cystic hemangioblastoma].

Authors:  P Tridon; J Montaut; L Picard; M Weber; J M André
Journal:  Rev Neurol (Paris)       Date:  1969-08       Impact factor: 2.607

7.  [Cataplexy associated with Gélineau's disease; effect of clomipramine].

Authors:  P Passouant; M Baldy-Moulinier; C Aussilloux
Journal:  Rev Neurol (Paris)       Date:  1970-07       Impact factor: 2.607

8.  [Polygraphic study of narcolepsy during the nycthemeral period].

Authors:  P Passouant; L Popoviciu; G Velok; M Baldy-Moulinier
Journal:  Rev Neurol (Paris)       Date:  1968-06       Impact factor: 2.607

9.  Amphetamine: differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine.

Authors:  K M Taylor; S H Snyder
Journal:  Science       Date:  1970-06-19       Impact factor: 47.728

10.  Stereochemical separation and configurational assignment by gas-liquid chromatography of N-trifluoroacetyl-L-prolyl amides of asymmetric I-phenylisopropylamines.

Authors:  A H Beckett; B Testa
Journal:  J Chromatogr       Date:  1972-07-05
View more
  5 in total

1.  Amphetamines, growth hormone and narcolepsy.

Authors:  J D Parkes; A G Debono; P Jenner; J Walters
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

2.  Kleine-Levin syndrome with periodic apnea during hypersomnic stages--E.E.G. study.

Authors:  J Vardi; S Flechter; M Tupilsky; J M Rabey; R Carasso; M Streifler
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

Review 3.  Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations.

Authors:  S Nishino; E Mignot
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

4.  Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Authors:  Kiran Maski; Lynn Marie Trotti; Suresh Kotagal; R Robert Auger; Todd J Swick; James A Rowley; Sarah D Hashmi; Nathaniel F Watson
Journal:  J Clin Sleep Med       Date:  2021-09-01       Impact factor: 4.324

Review 5.  Treatment paradigms for cataplexy in narcolepsy: past, present, and future.

Authors:  Todd J Swick
Journal:  Nat Sci Sleep       Date:  2015-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.